Ondas Inc. (ONDS)

The panel's take

Verdict: SELL · Conviction: LOW · Last price: USD 6.87 (as of 2026-07-21)

Ondas has gone from a small pre-revenue drone-and-wireless story to an aggressive, stock-funded roll-up of counter-drone and autonomous-systems businesses — Q1 2026 revenue rose 1,065% year-over-year to $50.1M, pro forma backlog reached $457M (+570%), and management has raised full-year 2026 revenue guidance twice, most recently to $525M. But the headline $361M Q1 net income is almost entirely a non-cash warrant-revaluation gain — the real operating loss actually widened to $42.7M — while shares outstanding have grown roughly 324–480% over the past year to fund the growth and the acquisitions. Two of the panel's three bearish voices object to the business itself rather than just the price — no durable moat, weak earnings quality, insider selling clustered at the 2026 highs — and even the panel's valuation specialist finds today's price above his own bull-case fair value. Against a single bullish framework and a weekly chart that has broken its uptrend, the synthesis is SELL at low conviction.

Key levels

Key resistance starts at the ~$9.00 shelf where the recent downtrend line and prior consolidation converge — the level the macro lens treats as the trigger for a more constructive read — then a falling trend-resistance band near $10.50 (close to where the weekly Supertrend indicator currently sits, ~$12.26), up to the 2026 high near $15.00. Key support sits at the ~$6.00 recent swing low, then a deeper Fibonacci-based zone near $3.60, with a historical accumulation zone near $2.00 marking the multi-year base the stock built before 2026's rally. The analyst consensus target spans USD 16 to 25, averaging near USD 19.50 — well above both the current price and every one of the panel's own valuation estimates, a large sell-side-versus-fundamentals gap that runs through much of the debate below.

What legendary investors think

We ran Ondas past a panel of six legendary investors' frameworks.

Where they agree — and where they clash

The question it comes down to: Is Ondas' backlog-driven growth converting into a durable, self-funding business before the next dilutive raise erodes shareholders further — or is this a story still being rewritten by acquisition every quarter, priced well ahead of any demonstrated operating leverage?

The numbers

Metric	Value
Price / Market cap	USD 6.87 / ~3.9B
P/E (TTM / fwd)	n/m (Q1 GAAP profit is a non-cash warrant gain) / n/a
ROE	n/a (operating loss)
Operating margin	~ -85% (Q1 2026 operating loss of $42.7M on $50.1M revenue)
Dividend yield	0%
Debt / equity	~0.02x (minimal debt against ~$1.48B cash)
Free cash flow	~ -USD 86.6M (LTM)

Figures as of Q1 2026 (reported May 2026) / July 20–21, 2026; sourced from Ondas Inc. IR/SEC filings, stockanalysis.com, GuruFocus, Seeking Alpha. Ondas' Q1 2026 GAAP net income of $361M was driven almost entirely by a $389.5M non-cash warrant-liability revaluation gain and a $51.5M deconsolidation gain, not operating performance — P/E and ROE are not meaningful figures on that basis.

The bottom line

What would tip this back toward a bullish read is proof the operating-leverage story is real: two or three consecutive quarters where adjusted EBITDA losses narrow on the schedule management has guided (product-level profitability by Q3 2026, platform-wide by Q1 2028), gross margin holding above 50%, and — most importantly — no further large stock-funded acquisitions or capital raises. A weekly close back above the ~$9.00 shelf on confirmed volume would also shift the technical read toward constructive. What would confirm the bearish case: another dilutive raise or stock-funded deal beyond the pending Cyberhawk close, a slip in the profitability timeline, or evidence that the $457M backlog is front-loaded with lower-margin hardware rather than the recurring, higher-margin revenue the bull case assumes. The DZYNE-related lockup shares (roughly 45M, released later in 2026) are a specific, dated overhang worth watching — a wave of selling into that unlock would be a real test of whether the stock can hold current levels.

The panel's take

Verdict: SELL · Conviction: LOW · Last price: USD 7.80 (as of 2026-07-25)

What changed since 2026-07-21:

• Price: USD 6.87 → USD 7.80 (+13.5%), driven by a $70M trailing-four-week wave of new defense/autonomous-systems orders — a real catalyst, not a fundamental re-rating; The Macro Opportunist still isn't chasing it into a hawkish Fed decision on July 28–29.
• Technical read upgraded, not reversed: the ~$6.20 swing low held on elevated volume and the stock closed near the top of its range — support is now "validated" rather than merely proposed — but the read stays "neutral, tilting cautiously constructive" because the ~$8.75–9.25 reclaim shelf still hasn't traded.
• Fundamental picture unchanged-to-worse: the DZYNE Technologies acquisition ($875.8M, closed) issued roughly 85M new shares, and a fresh 3.4M-share resale registration adds to the supply overhang The Moat Compounder and The Forensic Skeptic both flag as the same dilution pattern repeating, not resolving. Cash burn ($51.3M/quarter) and the non-cash nature of Q1's reported profit are unchanged — no newer quarter has reported.
• New risk/offset: The Intrinsic-Value Modeler raised conviction from Low-Medium to Medium as the gap between the DCF fair-value range and the now-higher price widened rather than closed. Offsetting that, The Disruptive-Innovation Seeker treats the order-flow acceleration as evidence the backlog-to-bookings conversion is genuinely inflecting, not just accumulating.
• Panel composition: unchanged — three bearish (Moat Compounder High, Intrinsic-Value Modeler Medium, Forensic Skeptic Medium), two neutral (GARP Operator Low, Macro Opportunist Low-Medium), one bullish (Disruptive-Innovation Seeker Medium). No perspective flipped its signal this week.
• Verdict: unchanged at SELL, conviction LOW.

The price recovery this week is real and volume-confirmed — Ondas held a genuine support test and bounced on contract-backed news, which is more than a low-volume dead-cat move. But nothing that moved the stock touched the three pillars the bearish majority of the panel weighs heaviest: the headline profit is still warrant-accounting noise rather than operating income, the growth is still being funded by handing out more shares (DZYNE plus a fresh resale filing), and the ~$9.00 reclaim shelf — the level every framework agreed would flip the technical read constructive — still hasn't traded. With the panel split essentially identical to last week's and no red flag resolved, the synthesis holds at SELL, low conviction: this reads as a genuine bounce inside an unresolved bearish structure, not a reversal of the thesis.

Key levels

Resistance is unchanged and untested this period: the $8.75–9.25 reclaim shelf was approached (week's high 8.58) but not closed above, then a falling band near $10.50, up to the January 2026 high near $15.00. Support at S1 is the one level that moved — the actual swing low (6.22, week of July 13) landed almost exactly on the prior $5.80–6.20 band and held on above-average volume, so it tightens to $6.20–6.55 as a validated level rather than an untested one; S2 ($3.60) and the historical accumulation zone at S3 ($2.00) remain untested. The analyst consensus target drifted marginally to an average near USD 19.81 within the same USD 16–25 range — still a wide gap above both the current price and every one of the panel's own fair-value estimates.

What legendary investors think

We ran Ondas past a panel of six legendary investors' frameworks.

Where they agree — and where they clash

The question it comes down to: Is the $70M order-and-guidance acceleration finally the proof of self-funding operating leverage the bull case needs — or is it once again arriving alongside an equity raise (DZYNE, the 3.4M-share resale) large enough to erase the per-share benefit before it ever shows up?

The numbers

Metric	Value
Price / Market cap	USD 7.80 / ~$4.4B (approx., scaled from the July 21 baseline of ~$3.9B at USD 6.87)
P/E (TTM / fwd)	n/m (Q1 GAAP profit is a non-cash warrant gain) / n/a
ROE	n/a (operating loss)
Operating margin	~ -85% (Q1 2026 operating loss of $42.7M on $50.1M revenue)
Dividend yield	0%
Debt / equity	~0.02x (minimal debt against a large cash position)
Free cash flow	~ -USD 86.6M (LTM)

Figures as of Q1 2026 (reported May 2026), unchanged since no newer quarter has reported as of 2026-07-25; price and order-flow figures as of July 22–25, 2026, sourced from The Motley Fool, GuruFocus, StocksToTrade, Yahoo Finance, Investing.com, and stockanalysis.com. Ondas' Q1 2026 GAAP net income of $361M remains driven almost entirely by non-cash warrant-liability revaluation and deconsolidation gains, not operating performance — P/E and ROE remain not meaningful on that basis.

The bottom line

What would tip this toward a bullish read: a weekly close above the ~$9.00 shelf on confirmed volume, and — separately — the August 17, 2026 Q2 earnings report showing adjusted EBITDA losses actually peaking as guided, with the $150M-plus in new orders converting to margin rather than just backlog, and no further large stock-funded deals after DZYNE. What would confirm the bearish case: a close back below the ~$6.20 support level (invalidating this week's bounce and opening the $3.60 zone), evidence the DZYNE-related lockup unlock or the new resale registration lands as heavy selling into the tape, or a Q2 report showing losses still widening despite the order growth. Until one of those resolves, the panel's majority view — real demand, funded by a still-growing share count, priced well below every valuation estimate on the desk but well above every panel member's own fair-value work — keeps the synthesis at SELL, low conviction.

The panel's take

Verdict: WAIT · Conviction: MEDIUM · Last price: USD 7.80 (as of 2026-08-01) · Changed from SELL

What changed since 2026-07-25:

• Price: USD 7.80 → USD 7.80 (+0.00%)
• Panel: 1 of 6 → 0 of 6 now Bullish — composition also changed: added The Activist Catalyst, The Asymmetric Bargainer; removed The Macro Opportunist, The Moat Compounder
• Trigger: BUY trigger: weekly close above USD 8.77 (EMA20 + 50% weekly Fib confluence) with expanding volume, confirming the correction is over and the weekly trend reclaimed. SELL trigger: weekly close below USD 7.23 (weekly 61.8% Fib), confirming a deeper correction into Stage 4 decline targeting USD 6.03 and potentially the USD 5.30 volume gap.
• Verdict: SELL → WAIT

Last month's panel split was SELL with low conviction, driven by a bullish-disruptive minority arguing against a cautious majority. This month, bullish voices went to zero and the two new additions — The Activist Catalyst and The Asymmetric Bargainer — both landed bearish on BUSINESS rather than PRICE/TIMING, shifting the panel's center of gravity from "maybe the price is wrong" to "the business quality itself is suspect." The price hasn't moved a cent (USD 7.80 both panels), but the reasoning has hardened: the CEO's $31.9M insider sale and the $220M cash-versus-earnings gap were already in the data last month; what changed is that two fresh analytical frameworks both independently flagged them as deal-breakers, converting a cautious-LOW SELL into a more confident MEDIUM WAIT where the trigger for action is a clear technical reclaim, not a price drop.

The split is BUY vs WAIT, not BUY vs SELL. The fundamental and sentiment reads lean bullish on the business, while The Intrinsic-Value Modeler and The Disruptive-Innovation Seeker both explicitly endorse the business thesis but want a lower price or technical confirmation — classic PRICE/TIMING objections. The Forensic Skeptic and The Activist Catalyst are true BUSINESS objectors (CEO insider sale, accounting mirage, FCF burn), but The Asymmetric Bargainer is also a BUSINESS objector (fails the Dhandho test on complexity/downside). However, the structure is decisively NOT BUY vs SELL — the dominant cautious position across four voices (technical read, The GARP Operator, The Disruptive-Innovation Seeker, The Intrinsic-Value Modeler) is "great business, wrong price/time," which maps cleanly to WAIT. The two true bears (The Forensic Skeptic, The Activist Catalyst) are outweighed by the price/timing camp, and the identifiable trigger — weekly close above USD 8.77 — makes WAIT the structurally correct verdict over HOLD.

Key levels

What legendary investors think

We ran Ondas Inc. past a panel of 6 legendary investors' frameworks.

Where they agree — and where they clash

The question it comes down to: Can Ondas convert its genuine regulatory moat and $525M FY26 revenue guidance into positive operating cash flow before the $1.47B cash cushion erodes — or does the CEO's $31.9M insider sale at $13.43 correctly signal that the execution gap is wider than the market believes?

The numbers

Metric	Value
Price / Market cap	USD 7.80 / n/a
P/E (TTM / fwd)	17.83x / n/a
ROE	42.95%
Operating margin	-89.47%
Dividend yield	n/a
Debt / equity	0.02x
Free cash flow	-USD 86.58M (TTM)

Figures as of 2026-08-01; sourced from stockanalysis.com (https://stockanalysis.com/stocks/onds/statistics/).

The bottom line

The stock's next move will be decided at USD 8.77 on a weekly closing basis — a close above that level with expanding volume would confirm the correction is over and the weekly uptrend has been reclaimed, which would shift the panel's dominant WAIT posture toward BUY. Conversely, a weekly close below USD 7.23 (the 61.8% Fibonacci retracement) would confirm a deeper correction targeting USD 6.03 and potentially the USD 5.30 monthly volume gap, which would validate the bearish faction's thesis that the CEO's $31.9M sale was prescient. The Q2 earnings report — specifically whether the $150M in bookings converts to cash revenue and whether operating cash flow narrows from -$83M — is the nearest fundamental catalyst that could resolve the debate before the chart does. Watch for any open-market insider purchases by the CEO or other C-suite executives; that single data point would override nearly every objection raised by the cautious voices. The $1.47B cash position buys time but does not buy conviction: until real cash earnings appear, the stock will remain a story trade, not an investment.

The panel's take

Verdict: SELL · Conviction: MED · Last price: 9.11 · Changed from WAIT

What changed since 2026-08-01:

• Price: 7.8 → 9.11 (+16.79%)
• Panel: 0 of 6 → 0 of 6 now Bullish — composition also changed: added The Structural Tailwind Rider; removed The Asymmetric Bargainer
• Trigger: Evidence of organic (non-acquisition) revenue growth with operating margins improving to at least -30% from -89%; management publicly committing to zero dilutive equity raises for 2+ years; and two consecutive quarters of positive free cash flow. A weekly close above $9.67 (volume POC) would also reopen the technical case.
• Verdict: WAIT → SELL

Since the prior WAIT verdict at $7.80, the price rallied 16.8% to $9.11, but the panel grew more cautious, not because the story changed, but because the rally stretched an already-thin fundamental case further. What tipped the verdict from WAIT to SELL was the dominance of BUSINESS objections (6 of 8 cautious voices): the skeptics aren't merely calling it expensive; they're calling the business model structurally flawed, citing a roll-up with no moat, phantom earnings, and 376% dilution that cannot be cured by a rising price alone.

The cautious camp is dominated by BUSINESS objections (6 of 8), not mere timing concerns. The Activist Catalyst (85% confidence), The Forensic Skeptic, The GARP Operator, The Disruptive-Innovation Seeker, The Structural Tailwind Rider, and the fundamental scout all identify structural flaws that go far beyond valuation: negative operating margins, 376% dilution in one year, no durable moat, phantom EPS from non-recurring gains, and a $5B market cap on negative FCF. The single bullish voice (sentiment-scout) reflects market euphoria, not independent business analysis. SELL tips from HOLD because the business-quality skeptics dominate the panel decisively.

Key levels

What legendary investors think

We ran Ondas Inc. past a panel of 6 legendary investors' frameworks.

Where they agree — and where they clash

The question it comes down to: Can Ondas convert its $457M backlog and $550M cash pile into sustainable, organic free cash flow before the dilution treadmill, or the market's patience, runs out?

The bottom line

• Trigger to confirm the breakdown: A weekly close below $7.80 (the monthly 50% Fibonacci retracement) would confirm the bearish MACD cross already in play and likely accelerate selling from momentum traders.
• The revenue test: FY2026 Q2 earnings must show the company on track for the $390M full-year guidance; any miss would fracture the 100% bullish analyst consensus that is currently propping up the narrative.
• Margin milestone to watch: Operating margin improving to at least –30% from the current –89% would be the first real signal that the business can scale profitably, rather than just buying revenue through acquisitions.
• Dilution red line: Any announcement of another dilutive equity raise, however small, would confirm the skeptics' core thesis that management prioritizes empire-building over per-share value and would likely trigger a rapid rerating lower.

The panel's take

Verdict: WAIT · Conviction: MED · Last price: 9.24 · Changed from SELL

What changed since 2026-08-08:

• Price: 9.11 → 9.24 (+1.43%)
• Panel: 0 of 6 → 1 of 6 now Bullish — composition also changed: added The Macro Opportunist, The Quality Rationalist; removed The Activist Catalyst, The Structural Tailwind Rider
• Trigger: BUY trigger: weekly close above $9.67 (volume POC) on expanding volume, confirmed by weekly MACD bullish cross and a Q3 print showing $140M+ revenue with improving gross margins. SELL trigger: weekly close below $8.82 (weekly EMA20), breaking the Stage 2 bull-trend structure, or a Q3 revenue miss below $120M indicating the H2 ramp is failing.
• Verdict: SELL → WAIT

The prior SELL verdict rested on a panel with zero outright bulls and a heavy lean toward the bearish side. The addition of The Macro Opportunist and The Quality Rationalist keeps the bearish contingent large, but The Disruptive-Innovation Seeker now stands as the lone Bull rather than one voice in a uniformly cautious chorus. The price barely moved — $9.11 to $9.24 — so the shift is entirely about conviction structure: the story hasn’t changed, but one archetype’s framework now registers it as a genuine asymmetric innovation bet rather than a trade to avoid, splitting the panel just enough to tip the call from SELL to WAIT.

The monthly Stage 2 trend and explosive revenue growth ($525M guided FY2026) make ONDS a genuine innovation story — not a broken business. But the split is structurally a BUY-vs-WAIT split: The Disruptive-Innovation Seeker is the lone outright Bull at current levels, while the non-Bullish camp is dominated by PRICE/TIMING objectors (Technical Scout, The GARP Operator, The Macro Opportunist) who like the business trajectory but want a lower entry or momentum confirmation. The BUSINESS objectors (The Forensic Skeptic, The Quality Rationalist) elevate the risk profile but don't shift the split — this remains a great-story/wrong-price setup, which maps to WAIT per Step B.

Key levels

What legendary investors think

We ran Ondas Inc. past a panel of 6 legendary investors' frameworks.

Where they agree — and where they clash

The question it comes down to: Can ONDS deliver roughly $400M in H2 revenue — a 4.8x sequential step-up from Q2 — without further dilution, contract delays, or margin deterioration, and if it does, will that translate into sustainable earnings per share after 9x share-count expansion?

The bottom line

• Trigger to confirm the breakout: A weekly close above $9.67 (the volume POC) on expanding volume with a weekly MACD bullish cross would resolve the Stage 2 consolidation in favor of continuation.
• Next catalyst: Q3 2026 earnings — due approximately November 2026 — must show revenue of $140M or higher with improving gross margins to validate the H2 ramp and keep the $525M full-year guidance credible.
• Risk to monitor: A weekly close below $8.82 (the weekly EMA20) breaks the bull-trend structure and opens a path to the monthly 50% Fib near $7.80, where the historical accumulation zone sits.
• Dilution watch: Any equity offering announcement in the next twelve months would undercut the per-share math that even the bull case depends on, given the share count has already expanded 9x since 2021.
• Further out: The Q4 2026 operating-platform EBITDA profitability target that management has guided becomes the next proving ground after Q3; slippage there would shift the margin-transition assumption from ambitious to unlikely.

The panel's take

Verdict: BALANCED · Conviction: MEDIUM · Last price: 8.71 · Changed from WAIT

Panel: 0 Bullish · 5 Neutral · 1 Bearish → BALANCED

What changed since 2026-08-15:

• Price: 9.24 → 8.71 (-5.74%)
• Panel: 1 of 6 → 0 of 6 now Bullish — composition also changed: added The Scuttlebutt Growth Investor; removed The Disruptive-Innovation Seeker
• Trigger: BUY on a weekly close above $9.67 (volume POC) with the weekly MACD histogram turning positive — confirming the correction is over and the monthly uptrend has re-engaged. SELL on a weekly close below $7.80 (monthly 50% Fib), which would invalidate the Stage 2 correction thesis and open the path to Stage 3 distribution.
• Verdict: WAIT → BALANCED

Six weeks ago, the panel issued WAIT with a Disruptive-Innovation Seeker in the bullish corner watching for a technical trigger. That trigger arrived: price closed at $8.71, below the $8.82 weekly EMA20, flipping the technical posture bearish. The panel replaced a growth-at-any-price voice with the Scuttlebutt Growth Investor, whose The Scuttlebutt Growth Investor checklist rejection of the underlying business quality reinforced the cautious shift. The result is a BALANCED — the breakdown is real enough to rule out buying, but the net-cash floor and the unbroken monthly uptrend keep the bearish argument from carrying the panel.

The prior WAIT trigger fired — price closed at $8.71, below the $8.82 weekly EMA20 trigger, which by its own terms should flip the verdict bearish. Four of the six voices (including both technicians) explicitly note this breakdown and refuse to endorse buying while it persists. But five of six land Neutral, not Bearish: the bearish-trigger argument is outweighed by the fortress balance sheet ($1.17/share net cash), the explosive but unmonetized revenue growth, and the fact that $8.71 sits directly on the weekly 61.8% Fib ($8.64) — a make-or-break level that has not yet failed. The Quality Rationalist alone votes Bearish on the business itself (poor earnings quality, insider selling, negative margins), not on price. The panel therefore holds: the breakdown is real but the floor is nearby, and the bull case is intact if price stabilizes here.

Key levels

Key support at $8.64, the weekly 61.8% Fibonacci retracement of the $4.53–$15.28 swing — price closed at $8.71, sitting directly on this level, a classic retracement test that has not yet failed. Below that, $7.80 (monthly 50% Fib) is the next major support and the level that would invalidate the Stage 2 correction thesis if broken. Key resistance at $9.67, the volume profile point of control where the heaviest historical volume sits above current price — a weekly close above it would confirm the correction is done. Analyst consensus target of $19.28 sits well above all near-term resistance, reflecting 121% upside if the revenue ramp materializes.

What legendary investors think

We ran Ondas Inc. past a panel of 6 legendary investors' frameworks.

Where they agree — and where they clash

The question it comes down to: Can Ondas convert its explosive but unmonetized revenue growth and $613 million backlog into positive operating cash flow before the stock's weekly technical correction deepens into a Stage 3 distribution breakdown?

The bottom line

• Trigger to confirm the correction is over: A weekly close above $9.67 (volume POC) accompanied by the weekly MACD histogram turning positive would signal the monthly uptrend has re-engaged.
• Level that invalidates the bullish structure: A weekly close below $7.80 — the monthly 50% Fibonacci retracement — would confirm Stage 3 distribution and open materially deeper downside.
• Next catalyst: The H2 2026 revenue ramp requires $391–416 million in reported revenue; any miss on that guided range would collapse the thesis, while hitting or exceeding it would shift attention to operating-cash-flow trajectory.
• Fundamental milestone to watch: Two consecutive quarters of positive operating cash flow and operating margins turning positive would address the panel's single largest concern and could re-rate the stock even before technicals confirm.
• Risk to monitor: Continued insider selling without any insider buying, or a further equity raise that compounds the existing dilution from the $860 million FY2025 issuance, would signal management sees more risk ahead than their public commentary suggests.